0001209191-17-065792.txt : 20171214
0001209191-17-065792.hdr.sgml : 20171214
20171214210706
ACCESSION NUMBER: 0001209191-17-065792
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171208
FILED AS OF DATE: 20171214
DATE AS OF CHANGE: 20171214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FOLETTA MARK G
CENTRAL INDEX KEY: 0001236389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38052
FILM NUMBER: 171257489
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS INC
STREET 2: 9360 TOWNE CENTRE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tocagen Inc
CENTRAL INDEX KEY: 0001419041
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261243872
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3030 BUNKER HILL STREET, SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92109
BUSINESS PHONE: (858) 412-8400
MAIL ADDRESS:
STREET 1: 3030 BUNKER HILL STREET, SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92109
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-08
0
0001419041
Tocagen Inc
TOCA
0001236389
FOLETTA MARK G
C/O TOCAGEN INC.
3030 BUNKER HILL, STE. 230
SAN DIEGO
CA
92109
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2017-12-08
5
J
0
E
2500
8.50
A
7500
D
This Form 4 is being filed voluntarily to report the acquisition of 2,500 shares by the Reporting Person on December 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan.
/s/ Mark Foletta
2017-12-14